- Home
- ETSY vs GH Comparison
ETSY vs GH Comparison
Compare ETSY & GH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETSY
- GH
- Stock Information
- Founded
- ETSY 2005
- GH 2011
- Country
- ETSY United States
- GH United States
- Employees
- ETSY N/A
- GH N/A
- Industry
- ETSY Business Services
- GH Medical Specialities
- Sector
- ETSY Consumer Discretionary
- GH Health Care
- Exchange
- ETSY Nasdaq
- GH Nasdaq
- Market Cap
- ETSY 5.8B
- GH 4.9B
- IPO Year
- ETSY 2015
- GH 2018
- Fundamental
- Price
- ETSY $63.40
- GH $45.59
- Analyst Decision
- ETSY Hold
- GH Strong Buy
- Analyst Count
- ETSY 26
- GH 20
- Target Price
- ETSY $51.63
- GH $54.35
- AVG Volume (30 Days)
- ETSY 4.8M
- GH 1.9M
- Earning Date
- ETSY 07-30-2025
- GH 07-30-2025
- Dividend Yield
- ETSY N/A
- GH N/A
- EPS Growth
- ETSY N/A
- GH N/A
- EPS
- ETSY 1.54
- GH N/A
- Revenue
- ETSY $2,813,554,000.00
- GH $773,996,000.00
- Revenue This Year
- ETSY $0.77
- GH $23.37
- Revenue Next Year
- ETSY $1.59
- GH $21.31
- P/E Ratio
- ETSY $41.23
- GH N/A
- Revenue Growth
- ETSY 2.18
- GH 28.20
- 52 Week Low
- ETSY $40.05
- GH $20.14
- 52 Week High
- ETSY $66.18
- GH $53.42
- Technical
- Relative Strength Index (RSI)
- ETSY 66.44
- GH 39.86
- Support Level
- ETSY $54.93
- GH $48.90
- Resistance Level
- ETSY $61.37
- GH $49.30
- Average True Range (ATR)
- ETSY 1.94
- GH 1.80
- MACD
- ETSY 0.61
- GH -0.76
- Stochastic Oscillator
- ETSY 94.88
- GH 14.40
About ETSY Etsy Inc.
Etsy operates a top-10 e-commerce marketplace in the US and the UK, with sizable operations in Germany, France, Australia, and Canada. The firm dominates an interesting niche, connecting buyers and sellers through its online market to exchange vintage and craft goods. With $12.5 billion in 2024 consolidated gross merchandise volume, Etsy has cemented itself as one of the largest players in a quickly growing space, generating revenue from listing fees, commissions on sold items, advertising services, payment processing, and shipping labels. The firm connects about 95 million buyers and 8 million sellers on its marketplace properties: Etsy and Depop (clothing resale).
About GH Guardant Health Inc.
Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.